> but the mRNA approach seems obviously more general and even perhaps more re-usable We should also see how subunit protein vaccines such as Novavax will perfo

> but the mRNA approach seems obviously more general and even perhaps more re-usable We should also see how subunit protein vaccines such as Novavax will perform once they are widely available. From what it looks they should be equally effective and more anti-vaxxer friendly.